Related Experiment Video
Updated: Aug 23, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides
Ken J Ishii1, Ihsan Gursel, Mayda Gursel
1Akira Innate Immunity Project, ERATO, Japan Science and Technology Agency, Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Osaka 565-0871, Japan.
Abstract:
Bacterial DNA contains immunostimulatory CpG motifs that interact with toll-like receptor 9 on immune cells to stimulate the production of cytokines, chemokines and immunoglobulins. Synthetic oligodeoxynucleotides (ODNs) containing CpG motifs mimic the activity of bacterial DNA. Recently, several structurally distinct types of CpG ODN were identified that differentially activate human immune cells. These ODNs may be useful as vaccine adjuvants, anti-allergens and in the treatment of infectious diseases and cancer. Yet CpG-driven immune activation can have deleterious consequences, such as increasing the host's susceptibility to autoimmune disease. The immunomodulatory activity of CpG DNA can be blocked by DNA containing G-rich 'suppressive' motifs. The therapeutic potential of these immunostimulatory and immunosuppressive ODNs are discussed in this review.
Insights
CpG motifs in bacterial DNA activate immune cells via toll-like receptor 9. Synthetic CpG oligodeoxynucleotides (ODNs) show therapeutic potential but can also trigger autoimmune disease, necessitating careful application.
Area of Science:
- Immunology
- Molecular Biology
- Therapeutics
Background:
- Bacterial DNA contains CpG motifs that activate immune cells through toll-like receptor 9 (TLR9).
- Synthetic oligodeoxynucleotides (ODNs) containing CpG motifs mimic bacterial DNA's immunostimulatory effects.
- Different CpG ODN structures differentially activate human immune cells.
Purpose of the Study:
- To review the therapeutic potential of CpG ODNs as vaccine adjuvants, anti-allergens, and treatments for diseases.
- To discuss the dual nature of CpG ODNs, including their potential to exacerbate autoimmune conditions.
- To explore the role of G-rich suppressive motifs in blocking CpG DNA's immunomodulatory activity.
Main Methods:
- Review of scientific literature on CpG ODNs and their interaction with TLR9.
- Analysis of different CpG ODN structures and their immune activation profiles.
- Discussion of therapeutic applications and potential adverse effects.
Main Results:
- CpG ODNs can potently stimulate immune responses, including cytokine and immunoglobulin production.
- Structurally distinct CpG ODNs exhibit differential activation of human immune cells.
- G-rich DNA motifs can suppress CpG-mediated immune activation.
Conclusions:
- CpG ODNs hold significant therapeutic promise for various conditions, including cancer and infectious diseases.
- The immunomodulatory effects of CpG ODNs necessitate careful consideration of potential autoimmune risks.
- Understanding and manipulating CpG ODN activity, including suppressive motifs, is crucial for safe and effective therapeutic development.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antiviral Nucleoside Inhibitors

